The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
NEJM study shows strong protection across strains
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Approval strengthens the company’s growing international anti-infective portfolio
Subscribe To Our Newsletter & Stay Updated
